USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: NACELLE THERAPEUTICS, INC.
City: MANHATTAN
State: KS
Zip+4: 66502
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: (785) 532-3906

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $527,945.00 3

Award List:

CHANNEL REPLACEMENT THERAPY FOR CYSTIC FIBROSIS

Award Year / Program / Phase: 2002 / SBIR / Phase I
Agency: HHS
Principal Investigator: John M. Tomich
Award Amount: $195,000.00
Abstract:
Nacelle's overall objective is to develop and commercialize a superior cystic fibrosis (CF) therapeutic, derived from a family of unique peptides that will form functional ion channels in defective cell membranes. Nacelle Therapeutics refers to this treatment modality as "Peptide-based channel… More

SYNTHETIC PEPTIDE MODULATORS OF PARACELLULAR CONDUCTANCE

Award Year / Program / Phase: 2002 / SBIR / Phase I
Agency: HHS
Principal Investigator: John M. Tomich
Award Amount: $100,000.00
Abstract:
DESCRIPTION (provided by applicant): The innovative use of a synthetic peptide to modulate epithelial or endothelial cell-cell interactions is proposed for the augmentation of drug- or gene-based therapeutic interventions. Cell monolayers are a major obstacle to delivering drugs to selected… More

Enhanced Drug Access to Eye Tissues

Award Year / Program / Phase: 2004 / SBIR / Phase I
Agency: HHS
Principal Investigator: John M. Tomich
Award Amount: $232,945.00
Abstract:
DESCRIPTION (provided by applicant) The innovative use of a synthetic peptide to modulate epithelial cell-cell interactions is proposed for the augmentation of drug- or gene-based therapeutic interventions. Cell monolayers are a major obstacle to delivering drugs to selected locations throughout the… More